The Spanish health ministry is consulting on a draft royal decree to update and clarify key aspects of existing regulation for setting prices and financing medicines available on the national health system (SNS). Measures proposed include the possibility of reviewing prices of medicines that are already reimbursed and establishing criteria for authorizing accelerated reimbursement.
Spanish Health Ministry Targets Efficiency With New Medicine Pricing Rules
A draft royal decree would pave the way for more transparency in pricing and reimbursement decision-making processes and boost competition to increase the participation of generic medicines.
More from Spain
• By
The first reimbursement reports published by the Spanish health ministry to improve transparency focus on CSL’s Hemgenix, BMS’ Camzyos and Pfizer’s Velsipity.
• By
CSL Behring explains how it worked with authorities in Denmark, Austria, England, Scotland, Spain and Switzerland to secure innovative access arrangements suitable to each nation’s “unique needs” for its one-time gene therapy, Hemgenix.
• By
The strategy includes a committee made up of pharmaceutical industry representatives and ministers to discuss the impact of regulatory proposals.
• By
A draft royal decree would pave the way for more transparency in pricing and reimbursement decision-making processes and boost competition to increase the participation of generic medicines.
More from Market Access
• By
A former CMS manager worries casework and other necessary functions could suffer as a result of the 300 staff cuts at the agency that are part of a massive HHS restructuring.
• By
About 3,500 full-time FDA employees are expected to be laid off as part of a restructuring of the Health and Human Services Department and experts questioned whether the cuts could be implemented without harming FDA’s core mission.
• By
A German ordinance implementing the EU Health Technology Assessment Regulation offers little clarity on how far joint clinical assessment reports should be considered by national authorities.